172 related articles for article (PubMed ID: 36772872)
1. Utilizing mixture design response surface methodology to determine effective combinations of plant derived compounds as prostate cancer treatments.
Berlin IG; Jennings CC; Shin S; Kenealey J
Cancer Rep (Hoboken); 2023 Apr; 6(4):e1790. PubMed ID: 36772872
[TBL] [Abstract][Full Text] [Related]
2. Application of Mixture Design Response Surface Methodology for Combination Chemotherapy in PC-3 Human Prostate Cancer Cells.
Oblad R; Doughty H; Lawson J; Christensen M; Kenealey J
Mol Pharmacol; 2018 Aug; 94(2):907-916. PubMed ID: 29884690
[TBL] [Abstract][Full Text] [Related]
3. γ-Tocotrienol and α-Tocopherol Ether Acetate Enhance Docetaxel Activity in Drug-Resistant Prostate Cancer Cells.
Asay S; Graham A; Hollingsworth S; Barnes B; Oblad RV; Michaelis DJ; Kenealey JD
Molecules; 2020 Jan; 25(2):. PubMed ID: 31963634
[TBL] [Abstract][Full Text] [Related]
4. Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells.
Mantena SK; Sharma SD; Katiyar SK
Mol Cancer Ther; 2006 Feb; 5(2):296-308. PubMed ID: 16505103
[TBL] [Abstract][Full Text] [Related]
5. Response surface methodology optimizes selenium inhibition of prostate cancer PC-3 cell viability.
Whitcomb A; Li X; Lawson J; Christensen M
J Trace Elem Med Biol; 2024 Jul; 84():127414. PubMed ID: 38489924
[TBL] [Abstract][Full Text] [Related]
6. 4-Nerolidylcatechol (4-NC) and Docetaxel Synergize in Controlling Androgen- independent Prostate Cancer Cells.
da Silva Guimarães G; Cordeiro AO; Gazolla MC; Vecchi L; Pereira Zoia MA; de Vasconcelos Azevedo FVP; Moreira Campos I; de Souza Costa D; Soares Mota ST; Alves Ribeiro M; Goulart LR; da Silva Filho AA; Araújo TG
Curr Top Med Chem; 2023; 23(11):943-955. PubMed ID: 36748811
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of natural bioactive compounds against prostate cancer: Molecular targets and synergistic activities.
Mia MAR; Dey D; Sakib MR; Biswas MY; Prottay AAS; Paul N; Rimti FH; Abdullah Y; Biswas P; Iftehimul M; Paul P; Sarkar C; El-Nashar HAS; El-Shazly M; Islam MT
Phytother Res; 2023 Dec; 37(12):5724-5754. PubMed ID: 37786304
[TBL] [Abstract][Full Text] [Related]
8. Emodin induces apoptosis in human prostate cancer cell LNCaP.
Yu CX; Zhang XQ; Kang LD; Zhang PJ; Chen WW; Liu WW; Liu QW; Zhang JY
Asian J Androl; 2008 Jul; 10(4):625-34. PubMed ID: 18478162
[TBL] [Abstract][Full Text] [Related]
9. Genistein combined polysaccharide enhances activity of docetaxel, bicalutamide and Src kinase inhibition in androgen-dependent and independent prostate cancer cell lines.
Burich RA; Holland WS; Vinall RL; Tepper C; White RW; Mack PC
BJU Int; 2008 Nov; 102(10):1458-66. PubMed ID: 18565171
[TBL] [Abstract][Full Text] [Related]
10. Berberine inhibits the proliferation of prostate cancer cells and induces G₀/G₁ or G₂/M phase arrest at different concentrations.
Lu W; Du S; Wang J
Mol Med Rep; 2015 May; 11(5):3920-4. PubMed ID: 25572870
[TBL] [Abstract][Full Text] [Related]
11. 3,6-diazabicyclo[3.3.1]heptanes Induces Apoptosis and Arrests Cell Cycle in Prostate Cancer Cells.
Wei H; Lian W; Wang C
Med Sci Monit; 2020 Jan; 26():e920266. PubMed ID: 31919338
[TBL] [Abstract][Full Text] [Related]
12. Berberine targets epidermal growth factor receptor signaling to suppress prostate cancer proliferation in vitro.
Huang ZH; Zheng HF; Wang WL; Wang Y; Zhong LF; Wu JL; Li QX
Mol Med Rep; 2015 Mar; 11(3):2125-8. PubMed ID: 25394789
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin enhances the susceptibility of both androgen-dependent and -independent prostate carcinoma cells to docetaxel.
Liu QJ; Xu XH; Shang DH; Tian Y; Lü WC; Zhang YH
Chin Med J (Engl); 2010 Feb; 123(3):356-60. PubMed ID: 20193259
[TBL] [Abstract][Full Text] [Related]
14. The Combination of Omega-3 Stearidonic Acid and Docetaxel Enhances Cell Death over Docetaxel Alone in Human Prostate Cancer Cells.
Mansour M; van Ginkel S; Dennis JC; Mason B; Elhussin I; Abbott K; Pondugula SR; Samuel T; Morrison E
J Cancer; 2018; 9(23):4536-4546. PubMed ID: 30519360
[No Abstract] [Full Text] [Related]
15. Effects of Resveratrol, Berberine and Their Combinations on Reactive Oxygen Species, Survival and Apoptosis in Human Squamous Carcinoma (SCC-25) Cells.
Skonieczna M; Hudy D; Poterala-Hejmo A; Hejmo T; Buldak RJ; Dziedzic A
Anticancer Agents Med Chem; 2019; 19(9):1161-1171. PubMed ID: 30950357
[TBL] [Abstract][Full Text] [Related]
16. Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells.
Choi MS; Oh JH; Kim SM; Jung HY; Yoo HS; Lee YM; Moon DC; Han SB; Hong JT
Int J Oncol; 2009 May; 34(5):1221-30. PubMed ID: 19360335
[TBL] [Abstract][Full Text] [Related]
17. Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments.
Maiti P; Plemmons A; Dunbar GL
PLoS One; 2019; 14(12):e0225660. PubMed ID: 31841506
[TBL] [Abstract][Full Text] [Related]
18. Emodin inhibits the proliferation of PC3 prostate cancer cells in vitro via the Notch signaling pathway.
Deng G; Ju X; Meng Q; Yu ZJ; Ma LB
Mol Med Rep; 2015 Sep; 12(3):4427-4433. PubMed ID: 26081222
[TBL] [Abstract][Full Text] [Related]
19. Rh2 or its aglycone aPPD in combination with docetaxel for treatment of prostate cancer.
Musende AG; Eberding A; Jia W; Ramsay E; Bally MB; Guns ET
Prostate; 2010 Sep; 70(13):1437-47. PubMed ID: 20687217
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial protein cyclophilin-D-mediated programmed necrosis attributes to berberine-induced cytotoxicity in cultured prostate cancer cells.
Zhang LY; Wu YL; Gao XH; Guo F
Biochem Biophys Res Commun; 2014 Jul; 450(1):697-703. PubMed ID: 24946211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
